Abiopharma

🔍 Hug Joshua (Director)

Company: Remitly Global, Inc. (RELY)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Sold 16,800 shares of Common Stock at $21.56 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,533,503.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 16,800 shares of Common Stock at $21.66 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,516,703.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-29 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 300,000.00 | Footnotes: F4

Footnotes:

• F1: This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2025.
• F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $21.41 to $21.68 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
• F3: Weighted average price. These shares were sold in multiple transactions at prices ranging from $21.51 to $21.82 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
• F4: The securities are held by a family trust, of which the reporting person's spouse is the trustee.